Open Journal of Urology

Volume 4, Issue 6 (June 2014)

ISSN Print: 2160-5440   ISSN Online: 2160-5629

Google-based Impact Factor: 0.22  Citations  

Effect of Topical Steroid Treatment for Concealed Penis: Is It Managed Conservatively?

HTML  XML Download Download as PDF (Size: 269KB)  PP. 82-86  
DOI: 10.4236/oju.2014.46014    12,279 Downloads   14,126 Views  

ABSTRACT

Purpose: Phimosis can be treated using topical steroid treatment effectively. Meanwhile, concealed penis has been required surgical correction because it was considered stubborn to conservative treatment. But there were few reports of conservative treatment using topical steroid treatment for concealed penis. The aim of the present study was to evaluate the effects of topical steroid treatment for concealed penis. Materials and Methods: From December 2006 to December 2011, 30 patients (mean age 9.3 years) with concealed penis were treated with topical 0.12% bethamethasone valerate cream. Patients or their parents continued to retract the prepuce gently without causing pain and to apply a topical 0.12% bethamethasone valerate cream to the prepuce twice daily for 6 weeks. When topical steroid treatment was ineffective, patients were surgically corrected. Results: The success rate of topical steroid treatment was low (10%). 27 of 30 patients required surgical repair. No patients showed complications associated with topical steroid or surgical intervention. Conclusions: Concealed penis is highly resistant to topical steroid treatment and should be corrected surgically.

Share and Cite:

Aoki, K. , Fukui, S. , Takenaga, M. , Miyake, M. , Inoue, T. , Anai, S. , Torimoto, K. , Tanaka, N. and Fujimoto, K. (2014) Effect of Topical Steroid Treatment for Concealed Penis: Is It Managed Conservatively?. Open Journal of Urology, 4, 82-86. doi: 10.4236/oju.2014.46014.

Cited by

No relevant information.

Copyright © 2024 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.